国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pseudomonas aeruginosa Urease accessory protein UreG (ureG) CSB-YP488245EZY
CSB-EP488245EZY
CSB-BP488245EZY
CSB-MP488245EZY
CSB-EP488245EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP488246EZY1
CSB-EP488246EZY1
CSB-BP488246EZY1
CSB-MP488246EZY1
CSB-EP488246EZY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Putative reductase PLES_21131 (PLES_21131) CSB-YP488247EZY
CSB-EP488247EZY
CSB-BP488247EZY
CSB-MP488247EZY
CSB-EP488247EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Bifunctional protein HldE (hldE) CSB-YP488248EZY
CSB-EP488248EZY
CSB-BP488248EZY
CSB-MP488248EZY
CSB-EP488248EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP488249EZY
CSB-EP488249EZY
CSB-BP488249EZY
CSB-MP488249EZY
CSB-EP488249EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Glucans biosynthesis glucosyltransferase H (opgH), partial CSB-YP488250EZY
CSB-EP488250EZY
CSB-BP488250EZY
CSB-MP488250EZY
CSB-EP488250EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Imidazoleglycerol-phosphate dehydratase (hisB) CSB-YP488251EZY
CSB-EP488251EZY
CSB-BP488251EZY
CSB-MP488251EZY
CSB-EP488251EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Homoserine O-acetyltransferase (metX) CSB-YP488252EZY
CSB-EP488252EZY
CSB-BP488252EZY
CSB-MP488252EZY
CSB-EP488252EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 8-amino-7-oxononanoate synthase (bioF) CSB-YP488253EZY
CSB-EP488253EZY
CSB-BP488253EZY
CSB-MP488253EZY
CSB-EP488253EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Multifunctional CCA protein (cca) CSB-YP488254EZY
CSB-EP488254EZY
CSB-BP488254EZY
CSB-MP488254EZY
CSB-EP488254EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Amino-acid acetyltransferase (argA) CSB-YP488255EZY
CSB-EP488255EZY
CSB-BP488255EZY
CSB-MP488255EZY
CSB-EP488255EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Tyrosine recombinase XerC (xerC) CSB-YP488256EZY
CSB-EP488256EZY
CSB-BP488256EZY
CSB-MP488256EZY
CSB-EP488256EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 4-hydroxybenzoate octaprenyltransferase (ubiA), partial CSB-YP488257EZY
CSB-EP488257EZY
CSB-BP488257EZY
CSB-MP488257EZY
CSB-EP488257EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 2-nonaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase (coq7) CSB-YP488258EZY
CSB-EP488258EZY
CSB-BP488258EZY
CSB-MP488258EZY
CSB-EP488258EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 50S ribosomal protein L7/L12 (rplL) CSB-YP488259EZY
CSB-EP488259EZY
CSB-BP488259EZY
CSB-MP488259EZY
CSB-EP488259EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 50S ribosomal protein L2 (rplB) CSB-YP488260EZY
CSB-EP488260EZY
CSB-BP488260EZY
CSB-MP488260EZY
CSB-EP488260EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 50S ribosomal protein L24 (rplX) CSB-YP488261EZY
CSB-EP488261EZY
CSB-BP488261EZY
CSB-MP488261EZY
CSB-EP488261EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 50S ribosomal protein L15 (rplO) CSB-YP488262EZY
CSB-EP488262EZY
CSB-BP488262EZY
CSB-MP488262EZY
CSB-EP488262EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Probable sugar efflux transporter (sotB), partial CSB-YP488263EZY
CSB-EP488263EZY
CSB-BP488263EZY
CSB-MP488263EZY
CSB-EP488263EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Pyridoxamine kinase (pdxY) CSB-YP488264EZY
CSB-EP488264EZY
CSB-BP488264EZY
CSB-MP488264EZY
CSB-EP488264EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>